← Leaderboards
Melody Smith
Stanford University
$835,380
Attributed
$835,380
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $167.1K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$835,380 · 1
By mechanism
K08$835,380 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Robert S Negrin$29,816,136
- Joseph C Wu$80,370,369
- Samuel Strober$36,157,957
- Anthony E Oro$25,372,453
- Edgar G. Engleman$35,389,843
Others in their field
Other Emerging Leaders on “Chimeric Antigen Receptor T Cells”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$21,497,910
- Crystal Mackall · Children'S Hosp Of Philadelphia$19,988,621
- Elizabeth Fox · St. Jude Children'S Research Hospital$8,840,232
- William H. Peranteau · Children'S Hosp Of Philadelphia$8,763,204
- Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med$7,776,394
- Kole T Roybal · J. David Gladstone Institutes$7,404,890
Research focus
Chimeric Antigen Receptor T CellsChimerismAllograft RejectionCellular Metabolic ProcessChimeric Antigen ReceptorAntitumor EffectAreaAttenuatedAdvisory CommitteesAutologousAllogenicB-Cell Acute Lymphoblastic LeukemiaBioinformaticsBone MarrowCareerCar T Cell TherapyCd19 GeneCell CountAttenuationAffectCell PhysiologyCellsCell TherapyClinical Data
Grant awards (5)
Investigating immunophenotype and metabolism of TCR KO donor and third-party CD19-targeted chimeric antigen receptor T cells$167,076
K08 · FY2025 · HL · contact PI
Investigating immunophenotype and metabolism of TCR KO donor and third-party CD19-targeted chimeric antigen receptor T cells$167,076
K08 · FY2024 · HL · contact PI
Investigating immunophenotype and metabolism of TCR KO donor and third-party CD19-targeted chimeric antigen receptor T cells$167,076
K08 · FY2023 · HL · contact PI
Investigating immunophenotype and metabolism of TCR KO donor and third-party CD19-targeted chimeric antigen receptor T cells$167,076
K08 · FY2022 · HL · contact PI
Investigating immunophenotype and metabolism of TCR KO donor and third-party CD19-targeted chimeric antigen receptor T cells$167,076
K08 · FY2021 · HL · contact PI